[Metabolism of aminoacetone and lead poisoning].

From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. Eur J Clin Invest (2010) 1.09

Cement, asbestos, and cement-asbestos pneumoconioses. Arch Environ Health (1975) 0.83

Does erythropoietin always win? Curr Med Chem (2014) 0.78

The erythropoietin and regenerative medicine: a lesson from fish. Eur J Clin Invest (2009) 0.77

A new therapy for kidney injury: regeneration. Eur Rev Med Pharmacol Sci (2011) 0.76

[Considerations on the subject of technical and biological prevention of saturnism]. Minerva Med (1966) 0.75

[Catabolism of amino ketones in hepatic insufficiency]. Boll Soc Ital Biol Sper (1964) 0.75

[Delta-aminolevulinic-dehydrase and delta-aminolevulinic-oxidase activity in subjects treated with nialamide]. Boll Soc Ital Biol Sper (1968) 0.75

[Aminoacetone in grave hepatic insufficiency]. Minerva Med (1967) 0.75

[Epidemiological study of silicosis among gneiss stone-cutters]. Med Lav (1967) 0.75

[The aminoacetone in neoplastic tissues]. Boll Soc Ital Biol Sper (1966) 0.75

[Statistical research with control sample on late pathologic findings in electrical injury patients]. Folia Med (Napoli) (1965) 0.75

[Rifampicin in therapy of pulmonary tuberculosis verified for the first time: clinico-causistic contribution]. G Ital Mal Torace (1969) 0.75

[Hemodynamic changes in acute experimental carbon monoxide poisoning. 2. Regional circulation (coronary, carotid, mesenteric renal, iliac)]. Med Lav (1969) 0.75

[Results of double-blind study with anticholinergic drugs]. Minerva Med (1973) 0.75

[Absenteeism due to disease in an industrial electric power plant]. Med Lav (1965) 0.75

The prevention of stress ulcers in a burn unit. Acta Chir Plast (1982) 0.75

[Contribution to the clinical diagnosis of neurotic tendencies in the work situation]. Med Lav (1969) 0.75

[Our experience in the treatment of the parkinsonian syndrome with L-dopa. I. Evaluation of the clinical results]. Riv Patol Nerv Ment (1969) 0.75

[Distribution of ALA-dehydrase and ALA-oxidase activity in rat organs]. Arch Sci Med (Torino) (1972) 0.75

[Contribution to the objective study of medical judgement. II. Study of the perceptive component of radiological diagnostic judgement]. Folia Med (Napoli) (1967) 0.75

[Oxidative deamination of aminoacetone in the rat liver]. Boll Soc Ital Biol Sper (1968) 0.75

[Experiences in the treatment of Parkinsonism with L-dopa. IV. Effects on the experimental extrapyranidal brady-akinesia in cats]. Riv Patol Nerv Ment (1970) 0.75

[Urinary excretion of aminoacetone in saturnism]. Boll Soc Ital Biol Sper (1964) 0.75

[Change of the pulmonary scintigraphic pattern caused by a new pyrazole derivative]. Minerva Med (1968) 0.75

[Evaluation of hazards caused by industrial toxic substance]. Arch Mal Prof (1970) 0.75

[Case of pulmonary silicosis of rapid development in a sandstone miner]. Folia Med (Napoli) (1968) 0.75

[Some aspects of noise in an industrial environment: research performed on a group of hydroelectric power plants]. Med Lav (1967) 0.75

[Delta aminolevulinic oxidase activity of human erythrocytes and plasma. II. Activity in various experimental conditions]. Boll Soc Ital Biol Sper (1967) 0.75

[In vitro effects of iproniazid on the ALA-dehydrase activity in the presence of metal ions]. Arch Sci Med (Torino) (1973) 0.75

[Removal of the inhibition of ALA-dehydrase caused by metals by iproniazid in rat liver homogenates]. Boll Soc Ital Biol Sper (1967) 0.75

[Delta-aminolevulinic-oxidative activity in neoplastic tissues of the digestive system]. Boll Soc Ital Biol Sper (1968) 0.75

[Contribution to the objective study of medical judgment. I. Preliminary study on interindividual variance of radiological judgment]. Folia Med (Napoli) (1967) 0.75

[On 2 cases of chronic pulmonary berylliosis. Problems of differential diagnosis]. Folia Med (Napoli) (1967) 0.75

[Porphyrin metabolism and heart diseases]. Arch Sci Med (Torino) (1968) 0.75

[Experiences in the treatment of Parkinsonism with L-dopa. 3. Laboratory findings in patients treated with L-dopa]. Riv Patol Nerv Ment (1970) 0.75

[Erythrocyte delta-aminolevulinic acid oxidative activity. 3. Activators and inhibitors]. Boll Soc Ital Biol Sper (1968) 0.75

[Ferrochelatase, ALA-dehydrase and ALA-synthetase activities in normal human tissues]. Arch Sci Med (Torino) (1967) 0.75

[Occupational risks and prevention in the rubber industry. II. Industrial and preventive hygiene]. Arch Sci Med (Torino) (1968) 0.75

Excretion kinetics of the rubber anti-oxidant N-isopropyl-N'-phenyl-p-phenylendiamine (IPPD). Int Arch Occup Environ Health (1987) 0.75

[Investigation of subjects exposed to mercury nitrate]. Arch Sci Med (Torino) (1981) 0.75

[The measurement of the risk of occupational otopathy in electric power plants]. Med Lav (1972) 0.75

[Delta-aminolevulinic oxidase activity of human erythrocytes and plasma. I. Normal values]. Boll Soc Ital Biol Sper (1967) 0.75

[Our experience with the treatment of the parkinsonian syndrome with L-dopa. II. Instrumental evaluation of the kinetic changes]. Riv Patol Nerv Ment (1969) 0.75

[Delta-aminolevulinic oxidase activity of rat liver homogenates in various experimental conditions]. Boll Soc Ital Biol Sper (1967) 0.75

[Work risks in the rubber industry and their prevention. I. Technological notes]. Arch Sci Med (Torino) (1968) 0.75

[Multidimensional psycho-medical research in a textile factory in northern Italy]. Med Lav (1975) 0.75